Company Filing History:
Years Active: 2004
Title: The Innovations of Mcihael Oettel
Introduction
Mcihael Oettel is a notable inventor based in Jena, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in developing treatments for side effects associated with GnRHa therapy. His work has the potential to improve the quality of life for many patients undergoing such treatments.
Latest Patents
Mcihael Oettel holds a patent for "Pharmaceutical preparations for treating side effects during and/or after GnRHa therapy." This innovative pharmaceutical preparation addresses side effects such as hot flashes, prostate enlargement, and gynecomastia. The formulation includes effective amounts of chemically modified derivatives of 17α-estradiol, 17β-estradiol, and estriol. Notably, preparations containing 14α, 15α-methylene-1,3,5(10),8-tetraene-3,17α-diol are particularly preferred.
Career Highlights
Oettel is associated with Jenapharm GmbH & Co. KG, where he has been instrumental in advancing pharmaceutical research and development. His expertise in the field has led to innovative solutions that address critical health issues.
Collaborations
Mcihael has collaborated with esteemed colleagues, including Ludwig Wildt and Peter Licht. Their combined efforts have contributed to the success of various projects within the pharmaceutical industry.
Conclusion
Mcihael Oettel's contributions to pharmaceutical innovations demonstrate his commitment to improving patient care. His patent for treating side effects during GnRHa therapy highlights the importance of research in developing effective medical solutions.